VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 >=16 µg/mL— 510(k) K172944

Substantially Equivalent

bioMerieux, Inc.

FDA 510(k) clearance K172944 for VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 >=16 µg/mL, Substantially Equivalent on 2017-12-19. Applicant: bioMerieux, Inc..

Clearance details

Applicant: bioMerieux, Inc.
Product code: Code LON
Advisory panel: Microbiology
Date received: 2017-09-26
Decision date: 2017-12-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hazelwood, MO, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code LON

product code LON

Malfunction: 2,383
Total: 2,383

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.